StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Quarterly UpdatesJul 27, 2026, 08:32 AM

Nuwellis Preliminary Q2 Revenue +14%, H1 Revenue +20%

AI Summary

Nuwellis, Inc. announced strong preliminary unaudited results for the second quarter and first half of 2026, with revenue growing 14% year-over-year for Q2 and 20% for the first six months. This growth is attributed to the continued commercial momentum of its Aquadex Ultrafiltration platform. The company plans to release its full financial results for the period on August 13, 2026, followed by a conference call and webcast.

Key Highlights

  • Preliminary Q2 2026 revenue year-over-year growth of 14%.
  • Preliminary first half 2026 revenue year-over-year growth of 20%.
  • Growth driven by the Aquadex Ultrafiltration platform.
  • Company to report full Q2 2026 financial results on August 13, 2026.
  • Conference call and webcast scheduled for August 13, 2026, at 9:00 a.m. Eastern Time.